Xin (Amy) Bu
About Xin (Amy) Bu
Xin (Amy) Bu is a Principal Scientist at Bristol-Myers Squibb with over 17 years of experience in pharmaceutical development and analytical support.
Current Position at Bristol-Myers Squibb
Xin (Amy) Bu currently holds the position of Principal Scientist at Bristol-Myers Squibb in New Jersey. In this role, she leads both pharmaceutical development teams and analytical project teams. Bu's responsibilities also include providing extensive analytical support for pharmaceutical development processes.
Previous Experience at HOECHST CELANESE CORPORATION
Before joining Bristol-Myers Squibb, Xin (Amy) Bu worked as a Research Chemist at HOECHST CELANESE CORPORATION. Her tenure at the Corpus Christi, Texas Area company lasted for one year from 1996 to 1997. During this time, she gained valuable experience in research chemistry, contributing to the corporation's chemical research initiatives.
Educational Background
Xin (Amy) Bu completed her Ph.D. in Analytical Chemistry from the University of Washington, where she studied from 1990 to 1995. Prior to that, she earned her Master of Science (M.Sc.) in Analytical Chemistry from Peking University, where she studied from 1982 to 1985. She also holds a Bachelor of Science (B.S.) in Chemistry from Peking University, completed between 1978 and 1982.
Experience in Pharmaceutical Industry
Xin (Amy) Bu has amassed over 17 years of experience in the pharmaceutical industry. Her focus has been primarily on pharmaceutical development and analytical support. Bu is proficient in method development, validation, and problem-solving within the pharmaceutical sector. She also has extensive experience in regulatory submissions, including registrational submissions.
Specialization in Method Development and Validation
With a specialization in method development, validation, and problem-solving, Xin (Amy) Bu brings a wealth of expertise to her role in the pharmaceutical industry. Her capabilities in these areas have been essential in ensuring the robustness and reliability of analytical methods used in pharmaceutical development and regulatory submissions.